How Is The Hematocrit Test Devices Market Size Forecasted To Progress From 2026 To 2030?
The hematocrit test devices market size has grown strongly in recent years. It will grow from $4.91 billion in 2025 to $5.22 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing prevalence of anemia and blood disorders, growth in hospital and laboratory diagnostic testing, rising demand for blood donor screening, expansion of emergency and trauma care services, growing awareness of hematocrit monitoring in clinical practice.
The hematocrit test devices market size is expected to see strong growth in the next few years. It will grow to $6.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rising demand for point-of-care diagnostics, increasing burden of chronic and lifestyle-related diseases, expansion of decentralized healthcare and home-based testing, growing investments in diagnostic infrastructure, increasing focus on early disease detection and preventive healthcare. Major trends in the forecast period include rising adoption of point-of-care hematocrit testing devices, growing demand for rapid and accurate blood parameter assessment, increasing use of portable and handheld hematocrit meters, expansion of hematocrit testing in emergency and critical care settings, rising focus on routine screening and chronic disease monitoring.
Claim Your Free Report Sample Today:
What Significant Demand Drivers Are Anticipated To Influence The Hematocrit Test Devices Market Over The Coming Years?
The growing cases of blood disorders are expected to propel the growth of the hematocrit test devices market going forward. A blood disorder is a condition that affects the components of human blood, including red blood cells, white blood cells, platelets, and blood plasma. Blood disorders are becoming more common due to several variables, including genetic predispositions, pollution in the environment, and lifestyle changes. Hematocrit test devices are primarily used to measure the volume percentage of red blood cells in whole blood, providing crucial information about the patient's hematological health. For instance, in January 2024, according to a report published by the American Cancer Society, a US-based non-profit organization, approximately 62,770 new cases of leukemia, encompassing all types, are anticipated in the United States in 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, primarily affecting adults, with approximately 11,220 deaths attributed to AML, almost exclusively occurring in adult patients. Therefore, the growing cases of blood disorders are driving the growth of the hematocrit test devices market.
What Segment Divisions Provide The Most Valuable Insights Into The Hematocrit Test Devices Market?
The hematocrit test devices market covered in this report is segmented –
1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables
2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications
3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users
Subsegments:
1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters
2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers
3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables
Which Strategic Trends Are Likely To Impact Competitive Positioning In The Hematocrit Test Devices Market?
Major companies in the hematocrit test device market are focusing on advanced technologies, including easy-to-use platforms designed for medium-volume laboratories. An easy-to-use platform is a system built with intuitive, user-friendly features that enable quick operation with minimal training. For example, in March 2024, Mindray, a China-based health technology company, introduced the BC-700 Series—a compact, integrated hematology analyzer for small to medium-sized labs that combines CBC and ESR testing into one device. It delivers results in just 1.5 minutes, boosting efficiency and workflow. The system uses SF Cube 3D analysis technology for accurate cell differentiation and includes the PLT-H parameter for improved platelet counting. By integrating CBC and ESR into a single unit, it reduces equipment and consumable costs. Available in both open vial and autoloader versions, the BC-700 Series provides reliable, automated, space-saving testing with strong correlation to traditional methods and enhanced safety and repeatability.
Who Are The Key Companies Actively Operating Within The Hematocrit Test Devices Market?
Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory LP, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.
Get Your In-Depth Hematocrit Test Devices Market Report Now:
Which Regions Are Projected To Advance The Fastest Over The Forecast Horizon In The Hematocrit Test Devices Market?
North America was the largest region in the hematocrit test devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment